Pharos iBio Balance Sheet Health
Financial Health criteria checks 6/6
Pharos iBio has a total shareholder equity of ₩22.9B and total debt of ₩0.0, which brings its debt-to-equity ratio to 0%. Its total assets and total liabilities are ₩23.7B and ₩839.9M respectively.
Key information
0%
Debt to equity ratio
₩0
Debt
| Interest coverage ratio | n/a |
| Cash | ₩19.51b |
| Equity | ₩22.87b |
| Total liabilities | ₩839.92m |
| Total assets | ₩23.71b |
Recent financial health updates
Financial Position Analysis
Short Term Liabilities: A388870's short term assets (₩20.3B) exceed its short term liabilities (₩784.0M).
Long Term Liabilities: A388870's short term assets (₩20.3B) exceed its long term liabilities (₩55.9M).
Debt to Equity History and Analysis
Debt Level: A388870 is debt free.
Reducing Debt: A388870 had no debt 5 years ago.
Balance Sheet
Cash Runway Analysis
For companies that have on average been loss-making in the past, we assess whether they have at least 1 year of cash runway.
Stable Cash Runway: A388870 has sufficient cash runway for more than a year based on its current free cash flow.
Forecast Cash Runway: A388870 has sufficient cash runway for 1.8 years if free cash flow continues to reduce at historical rates of 18.5% each year.